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ABSTRACT
Biochanin A, a nonsteroidal estrogen present in plants, has been suggested in epidemiological studies to be associated with a
reduced risk of hormone-related cancers. In this study, we examined the effects of biochanin A on the cell growth and gene expression
of an estrogen-responsive pituitary cell line GH3. Results showed that biochanin A inhibited growth of GH 3 cells in a dose-dependent
manner and at physiologically relevant concentrations. At concentrations of 1 and 5 µg/mL, inhibition of cell growth was observed.
The gene expressions of estrogen receptor (ER) mRNA and an estrogen responsive gene, the progesterone receptor (PR), were downregulated by the biochanin A treatment. In addition, co-administration of antiestrogen ICI182,780 blocked this biochanin A induced
down-regulation of the ER and PR mRNA level. However, the expression level of rat prolactin (rPRL) gene, one of the typical estrogen
responsive genes, was not regulated by biochanin A. These results indicated that biochanin A at physiologically achieveable concentrations was able to inhibit cell growth of estrogen-responsive rat pituitary cells. In addition, dietary-derived biochanin A compounds
exhibit diverse estrogenic and antiestrogenic effects on estrogen-related gene expression, suggesting gene-specific regulation.
Key words: dietary estrogen, pituitary cells, cell growth, gene expression

INTRODUCTION
Dietary phytoestrogens are naturally occurring constituents of plants that are known to elicit endocrine-modulation effects in animals(1,2). The richest sources of phytoestrogens among foodstuffs are legumes and grains, and the
amount of phytoestrogens in the soybean is on the order of
0.5 to 3 mg/g of soy proteins(3). Phytoestrogens have been
suspected to contribute to clover disease in grazing animals
that results in high abortion rates and permanent sterility (4).
Recently, epidemiological studies showed that the high contents of phytoestrogens present in traditional Asian diets are
associated with reduced risk of heart disease and hormonedependent cancers, including breast and prostate cancers,
and a decrease in menopausal symptoms(5,6). In vitro studies indicated that phytoestrogens were able to regulate cell
growth of breast tumor cells and induce cell death through
apoptosis(7,8). The mechanisms of action of phytoestrogens, especially in non-reproductive tissues, remain unclear
despite that fact that their biological effects on humans and
animals have been studied extensively in the recent years.
The effects of phytoestrogens have been investigated
in several model systems including human breast cancer
cells, endothelial cells, prostate cells and rat uterus.
Phytoestrogens have been found to increase proliferation of
human breast cancer cells at low concentrations but inhibit
cell growth at high concentrations (8,9). Stimulation of
estrogen responsive gene expression, increase in uterine
weight and regulation of cell cycle progression have also
* Author for correspondence. Tel: 886-2-28819471 ext 6858;
Fax: 886-2-28831193; E-mail: cying@mail.scu.edu.tw

been observed(3,10,11). Reports also showed that phytoestrogens exhibit inhibitory effects on the cell proliferation of
endothelial, ovary and prostate cells(12-14). However, concentrations higher than that found in serum after normal
consumption of phytoestrogen-containing food were often
required to demonstrate the effects of phytoestrogens on the
cell lines studied(15-17).
Little attention has been focused on the pituitary whose
function can be regulated by estrogen binding to its receptor
(estrogen receptor; ER). Using ER knockout mice, it has
been demonstrated that estrogen and its receptor play an
important role in lactotroph function in the pituitary(18). The
regulation of rat prolactin (rPRL) gene expression and
secretion has been found to involve estrogen(19,20). Upon
binding to its receptor estrogen can interact with the pituitary specific transcription factor Pit-1 to modulate rPRL
expression. To examine whether phytoestrogens that exhibit characteristics of estrogen and anti-estrogen affect pituitary cells, we analyzed the rat pituitary GH3 cell line’s
response to phytoestrogen on cell growth and gene activation. The results showed that biochanin A was able to regulate cell growth of GH3 cells at physiologically achievable
concentrations. In addition, differential effects on estrogenrelated gene expression were mediated by biochanin A in
these pituitary cells, suggesting a complex functional mechanism and tissue specific regulation of phytoestrogens.

MATERIALS AND METHODS
I. Cells and Culture Condition
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GH 3 cells, derived from rat pituitary tumors, were
obtained from American Type Cell Culture (ATCC). They
were grown in phenol red-free DMEM containing a 1X
antibiotic/antimycotic mixture, 5 mM N-(2-hydroxyethyl)
piperazine-N’-2-ethanesulfonic acid, and 0.37% sodium
bicarbonate. The medium was supplemented with either
10% FBS (fetal bovine serum) or 3X dextran/charcoalstripped FBS.
II. Cell Proliferation Assay
Cells were grown to confluence and subjected to
serum free DMEM for 24 hr. After reseeding into culture
flasks in DMEM containing 3X dextran/charcoal-stripped
FBS, cells were incubated with biochanin A for the
indicated time and cell proliferation was determined by the
trypan blue dye exclusion method.

then centrifuged and washed with ice-cold dilution buffer
(0.1% Triton X-100, 1% bovine hemoglobin, 20 mM TrisHCl, 0.14 M NaCl) for three times, and with TSA buffer
(20 mM Tris-HCl, 0.14 M NaCl) and 0.005 M Tris-HCl
(pH 6.8) once each at 4˚C. The resulting precipitated
immune complexes were solubilized at 100˚C for 3-5 min
in 20 µL of laemmli sample buffer. The solubilized proteins were fractionated by 12% SDS-PAGE and transblotted onto nitrocellulose membrane. After blocking
overnight at 4˚C in 5% skim milk in TBS buffer (20 mM
Tris-HCl, pH 7.5, 500 mM NaCl), the presence of ERalpha proteins in each sample was detected with ER175, an
antibody against ER-alpha protein. After washing with
TBS buffer, ER proteins present in the immune complexes
by immunoprecipitation were detected using alkaline phosphatase-conjugated goat anti-rabbit IgG antibodies and an
enhanced chemiluminescence (ECL) Western Blotting
System (Amersham).

III. Reverse Transcription-PCR (RT-PCR)
V. Statistical Analysis
Total RNA was prepared from cells and first reversetranscribed into cDNA, which in turn was subjected to PCR
amplification using primers specific for ER-alpha, rPRL
and PR. PCR amplification of the constitutively expressed
RPL19 (ribosomal protein L19) was used as a measure of
input RNA (21) . Controls containing water instead of
reverse transcribed RNA were used to demonstrate the
absence of contaminating DNA. The PCR products were
analyzed by electrophoresis in agarose gels and visualized
using ethidium bromide staining and UV light. The
sequences for ER-alpha, rPRL and PR were 5’-GGAGATTCTGATGATTGGTCT-3’ and 5’-CATCTCCAGGAGCAGGCTAT-3’; 5’-TCAGGAACTTGAGATAATTGT-3’
and 5’-CTGAAGACAAGGAACAAGCCCA-3’; 5’CCCACAGGAGTTTGTCAAACTC-3’ and 5’-TAACTTCAGACATCATTTCCGG-3’, respectively (22) . The
sequences for RPL19 primers were 5’-CTGAAGGTCAAAGGGAATGTG-3’ and 5’-GGACAGAGTCTTGATGATCTC-3’(21).
IV. Immunoprecipitation and Western Analysis
Cell lysates were prepared from cells treated with
biochanin A for 4 days as described(23). In brief, cells were
washed three times with ice-cold HBSS before the addition
of lysis buffer (0.1% Triton X-100, 1 mM iodoacetamide,
1% bovine hemoglobin, 1 mM PMSF, 0.002 U/mL aprotinin, 20 mM Tris-HCl, 0.14 M NaCl) and then incubated at
4˚C for 1 hr. Following centrifugation at 3000 xg for 10
min at 4˚C, the pellets were removed and the protein concentrations of the cell lysates were determined by Bradford
assays with bovine serum albumin as the standard. Samples
containing equal amounts of cellular proteins were incubated with ER-alpha antibody at 4˚C. Following gentle agitation overnight, 50 µL of protein A agarose previously equilibrated with lysis buffer was added to the reaction mixture
and incubated for 12 hr at 4˚C. The reaction mixture was

Data were analyzed by the orthogonal contrast test to
detect differences(24). Only p values < 0.01 were considered significant.

RESULTS
The potential effects of biochanin A on cell growth of
pituitary cells were measured (Figure 1A). The results
showed that biochanin A decreased the number of viable
cells in a dose-dependent manner and started to show
growth inhibitory effects at the concentration of 1 µg/mL at
4-day treatment. Biochanin A appeared to induce cell
growth arrest rather than cell death, since the percentage of
cell death was not significant at all concentrations used.
When the effects of biochanin A on GH3 cells were analyzed with WST-1 assay, similar observation was obtained
(data not shown). The WST-1 assay was based on the
quantitative detection of the formation of formazan derived
from the tetrazolium salt “WST-1” by the succinate-tetrazolium reductase system that beloned to the respiratory
chain of the mitochondria and is active only in viable cells.
Changes in cell morphology were observed in cells treated
with high concentrations of biochanin A (Figure 1B).
Condensation of the cellular components and decrease in
cell size were noticed. These cells remained attached to the
surface of the culture flasks and appeared transparent when
treated with trypan blue dye suggesting the possibility of
still being enclosed with cell membranes. Acridine orange
stain also suggested the occurrence of apparent condensed
chromosomes in these treated cells (data not shown). The
concentrations required for biochanin A to inhibit cell
growth might have physiological relevance since 11% and
22% inhibition was achieved at concentrations of 1 and 5
µg/mL, respectively. The reported plasma concentrations
of phytoestrogens after consumption of phytoestrogen-rich

9
Journal of Food and Drug Analysis, Vol. 12, No. 1, 2004

(A)

(B)
120
4-day
2-day

4

Number of cells (x10 )

100

80

60

40

20

0
0

1

1

5

10

20

40

50

60

100

Biochanin A concentration ( µg/mL)

Figure 1. The effects of biochanin A on GH3 cells. (A) GH3 cells
were incubated with biochanin A at the indicated concentration for 2
or 4 days and the numbers of viable cells were determined. Starting
cell number was 1.7x105/flask. (B) The cell morphology of biochanin
A treated GH 3 cells. Upper panel: cells treated with DMSO in
parallel; lower panel: cells treated with 100 µg/mL biochanin A for 4
days. The bar represents 10 µm.
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Figure 2. The effects of biochanin A on the mRNA levels of ERalpha, rPRL and PR in biochanin A treated GH3 cells. GH3 cells
were treated with biochanin A at the concentration of 0, 10, 40 or 100
µg/mL for 4 days and the level of ER-alpha mRNA, rPRL and PR
was individually detected using RT-PCR. The level of RPL19,
measured in parallel, was also determined as a control. H2O: water
substituted for DNA template in the PCR reaction.

Figure 3. The mRNA levels of ER-alpha, rPRL and PR in GH3 cells
after biochanin A was co-administrated with ICI182,780 or estrogen.
GH3 cells were incubated with 40 µg/mL biochanin A alone or simultaneously with antiestrogen ICI182,780 (1 or 8 µg/mL) or the
synthetic estrogen DES (100nM) for 4 days. The level of ER-alpha,
rPRL and PR mRNA was measured individually with RT-PCR
assays. H 2 O: water substituted for DNA template in the PCR
reaction.

food were in the range of 0.1-6 µg/mL.
Previous studies showed that estrogen exhibits selfregulation on its receptor-alpha (ER-alpha) at the levels of
mRNA and protein. In addition, estrogen has been shown
to activate the gene expression of rat prolactin (rPRL) and
progesterone receptor (PR) in pituitary cells. To investigate
whether the effects of biochanin A on cell growth is also
associated with ER-alpha, rPRL and PR in GH3 cells, we
measured the mRNA levels of these three genes in GH 3
cells by RT-PCR assays (Figure 2). The identity of these

amplified DNA products was confirmed by Southern blot
analysis using cloned DNA fragments as the probe. The
results show that the mRNA level of ER-alpha and PR was
down-regulated by 40 and 100 µg/mL biochanin A. The
levels of rPRL mRNA, on the other hand, did not appear to
be affected by the same treatment. Western analysis of the
rPRL protein levels in biochanin A treated-GH3 cells
showed similar results, in that rPRL protein level was
unchanged in the presence of biochanin A (data not shown).
Lower concentrations of biochanin A, although exhibiting
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cell growth inhibitory activity, did not cause detectable
changes in the level of ER and PR gene expression.
Pure antiestrogen ICI 182,790 or synthetic estrogen
DES was simultaneously added with biochanin A to
analyze the combined effect on ER-alpha gene expression
in GH3 cells and to examine the receptor specificity of
this regulation by biochanin A (Figure 3). Cells treated
with 40 µg/mL biochanin A and 8 µg/mL ICI182,790
simultaneously contained lower levels of ER-alpha
mRNA than cells treated with either compound alone.
The presence of both DES and biochanin A also resulted
in decrease of the ER-alpha mRNA levels in GH 3 cells.
Co-administration of DES and biochanin A exhibited
different effects on PR mRNA. The level of PR mRNA
in DES-treated cells was decreased by the addition of
biochanin A. The antiestrgoen ICI 182,780 alone interestingly caused significant down-regulation of PR mRNA.
It implies that biochanin A exhibits antiestrogenic activity
toward PR, especially at the basal expression level.
Administration of DES or ICI182,780 at the concentrations used in this study showed little, if there was any
effects on the number of viable GH3 cells.

DISCUSSION
Phytoestrogens have been shown to mediate multiple
estrogenic and antiestrogenic effects in different cell and
tissue types. The effects of phytoestrogens reported previously also appear to be concentration-dependent, in that
lower concentrations of phytoestrogens may stimulate cell
growth while high concentrations inhibit growth of the
same cells. In this study, we examined the effects of
biochanin A on GH3 a pituitary cell line to investigate the
potential roles of phytoestrogens on pituitary cell growth.
Our results showed that biochanin A inhibited the growth
of rat pituitary cells and down-regulated the gene expression of ER and PR. The expression of rPRL, on the other
hand, was not significantly affected by biochanin A.
Biochanin A was able to inhibit GH3 cell growth at concentrations of 1 and 5 µg/mL, which are within the range of
detected serum concentrations previously reported(16,17,25).
The vast majority of publications that describe the effects of
phytoestrogens in vitro have reported significant results at
concentrations higher than those achievable in vivo after
oral consumption of soy-based foods or products enriched
with phytoestrogens. For instance, Wang and Kurzer(8)
showed that the IC50 for biochanin A was 13 µg/mL and
the IC50 for genistein for cell growth was 10 µg/mL in
MDA-468 cells(26). Singhal and co-workers showed an
IC50 value of 18 µg/mL for quercetin in MDA-486 cells(27).
Although the physiological relevance of phytoestrogens at
these high concentrations has been argued, little is known
about the bioavailable concentrations of phytoestrogens in
tissues after consumption of soy-rich diet or the exact
targets of phytoestrogens in vivo(17,28,29). Nevertheless, in
GH3 cells, we have observed that biochanin A at the physi-

ological achievable concentrations was able to affect the
cell viability in a does-dependent manner.
At the concentrations that induced growth inhibition,
biochanin A showed little effect on the gene expression of
ER and PR. Down-regulation started to take place at higher
concentrations and resulted in 50-100% inhibition of cell
growth. This apparent disparity between the cell growth
and gene regulation has been reported in other estrogen
responsive pituitary cells by estrogen. The current hypothesis is that growth and gene regulation are controlled by
different percentages of “active” factors. Only a small pool
of these factors is required for growth regulation. At lower
concentrations, cell growth is preferentially affected while
gene regulation requires a higher concentration threshold.
Biochanin A induced down-regulation on mRNA levels in GH3 cells was detected only in the ER and PR, but not
in PRL. Similar down-regulation on ER-alpha mRNA levels induced by phytoestrogens was observed in human
breast cancer cells(9). However, previous studies showed
that other phytoestrogens were able to stimulate the secretion and expression of PRL in a rat pituitary cell line
PR1(30). This discrepancy might be due to different phytoestrogens used or the difference in the cell lines. Indeed,
their studies showed that only stimulation of the cell growth
was observed in this PR1 cell line at all phytoestrogen concentrations tested. The PR1 cells were originally desived
from an estrogen-induced pituitary tumor of F344 rats that
have been used as a model to study the impact of their high
sensitivity to estrogen. The extra high sensitivity toward
estrogen of this cell line compared to the GH3 cell line used
in this study might contribute to the difference in our results.
The concentrations of biochanin A that are required
for growth inhibition were physiologically achievable and
no significant cell death was detected at the highest concentration below 50 µg/mL. However, morphological changes,
including condensation of the cell contents and apparent
decrease in cell volume, were noted after treatment with
high concentrations of biochanin A. It would be interesting
to analyze and compare the molecular mechanisms in
pituitary cells with other cancer cell types such as breast
cancer cells. Several studies on breast and prostate cancer
cells indicate that phytoestrogens exhibit cytotoxic and/or
apoptotic effects and induce cell death at high concentrations. Our previous results showed that the level of
released lactate dehydrogenase (LDH) was induced by the
treatment of biochanin A in human breast cancer cells, suggesting biochanin A’s effects on cell membrane permeability(9). Although the LDH level was not examined fully in
GH3 cells upon exposure to biochanin A, was similar observation was expected since some cell death was detected
when GH3 cells were treated with 100 µg/mL biochanin A.
In the rat hypothalamus, a phytoestrogen, coumestrol,
increased the ER-beta mRNA signal by 47.5% while 17beta estradiol decreased this signal (31). The biological
functions of phytoestrogens are probably mediated through
multiple pathways. Cell, as well as tissue-specific regulation, might also be involved. In this study, the data

11
Journal of Food and Drug Analysis, Vol. 12, No. 1, 2004

indicated that the mRNA levels of ER-alpha and PR were
influenced by DES and biochanin A. However, the cell
growth was not inhibited by DES to the same degree as by
biochanin A. It thus appeared that the cell growth regulation by biochanin A in GH3 cells probably is not mediated
through the classical ER-alpha pathways. It is evident that
isoflavones are able to inhibit the cell growth in numerous
types of cells via action on the cell cycle. Biochanin A
may exhibit a regulation on cell cycle in GH3 cells as well.
Further investigation to identify the action target(s) in GH3
cells would certainly facilitate the understanding of the
effects of biochanin A on GH3 cells. Evidently, the neuroendocrine effects of phytoestrogens also require further
investigation since they have been suggested as an alternative or supplement to estrogen replacement therapy.
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